ABT vs SKYX · P/E 25, rev $44.33B vs rev $47.4M
Abbott Laboratories (ABT) versus SKYX Platforms Corp (SKYX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
SKYX Platforms Corp (SKYX) is a electrical equipment & parts company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SKYX revenue for 2026-06-30 was $47.4M. Net income was -$17.5M. SKYX currently screens at market cap $119.7M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SKYX currently screens at market cap $119.7M.
Not investment advice. Open the ABT and SKYX stock pages for the full models.
Not investment advice.